Skip to main content

Laser microgrooved vs. machined healing abutment disconnection/reconnection: a comparative clinical, radiographical and biochemical study with split-mouth design

Abstract

Background

Repeated removal and replacement of healing abutments result in frequent injuries to the soft tissues.

Purpose

The purpose of this study was to evaluate the effect of disconnection/reconnection of laser microgrooved vs. machined healing and prosthetic abutments on clinical periodontal parameters, marginal bone levels, and proinflammatory cytokine levels around dental implants.

Material and methods

Twenty-four patients each received 2 implants with one-stage protocol in a split-mouth design on the same jaw. In each patient, one healing and prosthetic abutments with a laser microgrooved surface (LMS group) and one healing and prosthetic abutments with machined surface (MS group) were used. Four months following implant placement (T0), the healing abutments were disconnnected and reconnected three times to carry out the impression procedures and metal framework try-in. Four weeks later (T1), definitive prosthetic abutments were installated with screw-retained crowns. Modified plaque index (mPI), modified gingival index (mGI) bleeding on probing (BOP), and probing depth (PD) were recorded at T0 and T1. At the same time points, samples for immunological analyses were taken from the sulcus around each implant. Peri-implant crevicular fluid (PICF) samples were analyzed for interleukin-1beta (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor (TNF)-α levels using the ELISA kit.

Results

At T0 and T1, mPI and mGI showed no statistical difference between the two groups, while higher PD and BoP values were noted for the MS group (P < 0.05). The mean PICF volume and mean concentrations of IL-1β, IL-6, and (TNF)-α in the LMS group were statistically less than those in the MS group (P < 0.05). In addition, comparison of IL-6 and IL-1β mean concentrations at T0 and T1 in the MS group showed a statistically significant increase (p < 0.05) over time, which was not noted for the LMS.

Conclusion

Disconnection/reconnection of healing and prosthetic abutments with a laser-microgrooved surface resulted in less inflammatory molecular response compared with conventional machined ones.

Trial registration

ClinicalTrials.govNCT04415801, registered 03/06/2020

Introduction

Over the years, some new configurations and topographic characterizations have been proposed and investigated in an attemp to improve the soft tissue attachment to the transmucosal part of dental implants [1,2,3,4,5,6,7,8,9,10,11,12,13]. One of the configurations is produced by a controlled laser ablation, which allows the formation of microgrooves with resolution within a micrometric range. In vitro experimental studies provided the hypothesis that laser-produced microgrooves in the range of 8 μm could be used to create a predetermined site on which a physical connective tissue attachment can be achieved [14,15,16,17]. Evaluating the effect of surface microgeometry in terms of cell attachment, proliferation, and orientation, cell culture studies showed that fibroblasts grown on 8-μm microgrooved surface become oriented and channeled in line with the grooves, whereas on a smooth/machined surface, fibroblasts growth was random. Subsequent histologic studies on humans demonstrated that, unlike fibers aligned in a parallel nonfunctional orientation around dental implants as fibrous capsules, fibers around 8-μm laser-microgrooved surfaces (LMS) have perpendicular, functional physical orientation [18,19,20]. This kind of attachment is similar to that of a natural tooth, which is an indispensable barrier against bacterial infection and other harmful stimuli. Attachment helps stabilize the peri-implant soft tissue and protect the peri-implant marginal bone. It has been also histologically documented in animal and human models that the peri-implant soft tissue seal developed using an 8-μm LMS on healing abutments can be transferred to another abutment with the same macro and micro-architecture [21,22,23]. A clinical question, however, remains unanswered: whether repeated removal and reattachment of LMS healing abutments for impression procedures and metal framework try-in disturbs and disrupts the mucosal seal. Repeated disconnection/reconnection of healing abutments with machined surfaces (MS) result in frequent injuries to the soft tissues [24], with subsequent tissue inflammation, apical downgrowth of junctional epithelium, and apical positioning of the connective tissue and crestal bone level changes [25]. To detect peri-implant soft tissue conditions by means of histologic analysis in humans is difficult. Ethical concerns such as harvesting gingival tissue around abutments in humans are major since it may affect long-term healing. A non-invasive method to study the response of inflamed tissues around teeth is the analysis of gingival crevicular fluid (GCF) [26]. In analogy, analysis of peri-implant crevicular fluid (PICF) was proposed [27, 28]. Similar to GCF, the PICF is an osmotically mediated inflammatory exudate which originates from the gingival vessel plexus. The composition of PICF is similar to gingival crevicular fluid, consisting of cells, host-derived enzymes and their inhibitors, inflammatory mediators, host response modifiers, and tissue breakdown products. Clinical studies comparing the inflammatory and immunological responses around implants and teeth found no significant difference between PICF and GCF volumes at either healthy or inflamed sites [27, 28]. Inflammatory and immune events were similar in the peri-implant mucosa and gingiva, and GCF and PICF production was governed by similar mechanisms, which depend on peri-implant tissue inflammatory conditions. Inflammation in peri-implant gingival tissues results in the activation of innate immune receptors, affecting the expression of proinflammatory cytokines which may be detected by analysis of PICF [29,30,31]. Changes in PICF flow rate and cytokine profiles may occur based on the health status of the peri-implant mucosa and may help in detecting early metabolic and biomechanical lesions in peri-implant soft tissues.

The present study aimed to evaluate, clinically and biochemically, the effect of repeated disconnection/reconnection of  LMS and MS healing abutments during restorative stages, on hard and soft tissue behavior.

Material and methods

Patients

Twenty-four partially edentulous patients (11 males and 13 females, mean age 47.3 years), requiring implant therapy for a prosthetic rehabilitation in at least two contralateral sites of the mandible or maxilla, participated in this study. Patients were included if they were 18 years or older, in good general health, with sufficient amount of bone available to place a standard implant (3.8 mm diameter and 9 mm length) detectable by means of CBCT evaluation, and with adequate width of keratinized tissue (≥ 2 mm) at the implant site.

None of the recruited patients had received antibiotics in the last 3 months prior to examination. Exclusion criteria were as follows: natural teeth adjacent to surgical area affected by untreated periodontal or endodontic infections, peri-implant bone defects requiring bone augmentation, absence of opposing occlusion, full-mouth plaque score (FMPS) ≥ 15%, full-mouth bleeding score (FMBS) ≥ 15% recorded at the time of implant placement, para-functional habits, severe maxilla–mandibular space discrepancies, uncontrolled diabetes and treatment with bisphosphonates, patients smoking > 10 cigarettes a day, and any drug/alcohol abuse.

Secondary exclusion criteria at implant surgery included a lack of primary implant stability or the need for a simultaneous hard tissue grafting. Secondary exclusion criteria at end of healing phase included FMPS and FMBS ≥ 15%, clinical signs of implant mobility, or any sign of peri- implant infection.

Each patient was informed about the evidence-based positive outcome of implant treatment and signed a free informed consent form after he/she has received detailed information about the study.

Treatments were performed according to the principles outlined in the Declaration of Helsinki on experimentation involving human subjects. The study was approved by the Research Ethics Committee of the La Sapienza University of Rome (#4597). Trial registration: ClinicalTrials.gov NCT04415801,registered 03/06/2020, https://register.clinicaltrials.gov/prs/app/action/SelectProtocol?sid=S0009V52&selectaction=Edit&uid=U0003LQX&ts=24&cx=-mviyyi.

The study duration was from May 2016 to September 2017, and it was accomplished in 2 phases, including healing period following implant placement (12/16 weeks) and a restorative phase (3 weeks) (Fig. 1).

Fig. 1
figure1

Overview of the study outline and follow-up visits

Implants

Forty-eight implants (Tapered Internal TRX, BioHorizons, AL, USA) were inserted by the same surgeons (RG, LT) using the same one-stage protocol in accordance with the manufacturer’s recommendations and with surgical procedures suggested for one-stage implant placement in partially edentulous patients.

Surgical and prosthetic protocol

Following local anesthesia, a crestal incision over the edentulous site was performed. After full-thickness flap elevation, osteotomy site was prepared using custom-made surgical template. After placement, one implant received a healing abutment with LMS (Laser-Lok© Healing Abutments, BioHorizons, AL, USA) (LMS group), while the contralateral implant received a healing abutment with MS (Standard Healing Abutment, BioHorizons, AL, USA) (MS Group). The MS abutments were entirely machined, while the LM abutments exhibited a partially (0.7 mm) microgrooved surface. The resulting circumferential horizontal mismatch (i.e., platform switch) was 0.65 and 0.6 mm for 4.3- and 5.0-mm implant diameters, respectively.

The single-stage approach prevents soft tissue covering the implant and corresponding cover cap during early postoperative period. A minimum distance of 1.5 mm between implant and adjacent teeth was maintained to preserve surrounding soft tissue and bone. Postoperative instructions included antimicrobial rinse (0.12% chlorhexidine rinse) and analgesics. Prescription medication use was recorded through patient diaries. Sutures were removed at week 1.

After 4 months (T0), the healing abutments were removed and placed in a saline solution. After taking the impression with direct pick-up coping and an open-tray, the healing abutments were reattached. The same procedure for removal and reattachment of the same healing abutment was repeated two additional times for the try-in of crown frame and the try-in of crown porcelain. Each time, the inside of the implant and the transmucosal area were rinsed with 0.2% chlorhexidine to eliminate foreign agents that induced inflammation. During the prosthesis delivery session, the laser-microgooved healing abutments were replaced with laser-microgrooved definitive prosthetic abutments (Laser-Lok© Easy Ti Abutments, BioHorizons, AL, USA), and smooth/machined healing abutments were replaced with smooth/machined definitive prosthetic abutments (Custom Castable UCLA Abutments, BioHorizons, AL, USA).

At T1, no rinsing with 0.2% chlorhexidine was performed. All implant-supported restorations were screw-retained single crowns. After delivery of the final restoration, patients were enrolled in a maintenance program with biyearly recalls. In Table 1, demographic data of the study population are reported.

Table 1 Demographics and healing/prosthetic abutment data of study population

Clinical data and sample collection

The clinical evaluation was performed by one clinician (RG). At T0 and T1 (Fig. 1), the following clinical parameters were assessed at each implant site using a pressure-calibrated (20–25 g) and color-coded plastic periodontal probe (Click-Probe® green, Kerr GmbH, Biberach, Germany): modified plaque index (mPI), modified gingival index (mGI), bleeding on probing (BoP), and probing depth (PD). mPI, mGI, BOP, and PD measurements were performed at 6 aspects per implant: mesiobuccal (mb), midbuccal (b), distobuccal (db), mesiooral (mo), midoral (o), and distooral (do). In addition, at T0 and T1, FMPS and FMBS were assessed

PICF sampling and biochemical analysis

The PICF was collected with standardized paper strips (Periopaper™, Proflow, Amityville, NY) at T1 and T2 by one clinician (RG). Following the isolation of the sampling area with sterile cotton gauzes, accurate suction was performed, and experimental sites were gently air dried to reduce any possible contamination with saliva. Supragingival plaque was removed with teflon or plastic curettes for implant maintenance. Extreme care was taken to minimize mechanical irritation during PICF sampling because this is known to affect the actual fluid volume. Two paper strips were placed at each sampling site at the same time (mesially and distally) and were left in situ for 30 s. Paper strips contaminated by blood were excluded. To eliminate the risk of evaporation, paper strips with PICF were immediately transported to previously calibrated Periotron 8000® (Ora Flow, Inc., Plainview, NY, USA) which was switched on and allowed to warm up for volume quantification. Before volume measurement, a blank paper strip was placed in the device, and the reading dial was set to zero. To increase reliability, the calibration of the device was checked periodically by triplicate readings. The PICF was measured electronically in Periotron units, which were converted to microliters (μl) by the MCCONVRT software (Ora Flow).

For the biochemical analysis, the paper strips were placed in a single Eppendorf vial containing 100 μl phosphate-buffered saline and stored at − 80 °C. Interleukins (IL-1β, IL-6) and tumor necrosis factor alpha (TNF-α) were quantified by enzyme-linked immunosorbent assay (ELISA) kits following the procedures recommended by the manufacturer (Duoset kit; R&D,Minneapolis, MN, USA). The standard solution and samples were added to wells, which had been precoated with specific monoclonal capture antibodies. After 3 h, polyclonal antibodies conjugated with horseradish peroxidase were added to each well and incubated for 1 h. A substrate solution containing hydrogen peroxidase and chromogen was added and allowed to react for 20 min. The biomarker levels were assessed by a micro-ELISA reader (Ultramark, Bio-Rad, CA, USA) at 450 nm and normalized to the abundance of standard solution. All biochemical analyses were performed by a blinded researcher.

Radiograph examination

Radiographs were performed at T0 and T1, with a paralleling technique using a Rinn film holder with a rigid film-object X-ray source. For the radiograph procedure, a silicone index material was fixated to the residual dentition, and a radiograph holder was constructed for each patient. This technique ensured that the same position of the radiograph film could be reproduced at each visit, and the angle of the radiograph would not deviate. The radiographs were taken in high-resolution mode (Vista Scan Durr Dental, Durr Dental Italy S.r.l) with a dental X-ray machine (TM 2002 Planmeca Proline CC, Planmeca Group Helsinki, Finland) equipped with a long tube that operated at 70 Kw/7.5 mA. Specialized software (DBSWIN software, Durr Dental Italy S.r.l) was used for linear measurements of marginal bone changes. The following radiographic measurements were performed:

  • radiographic implant length (IL): distance (in mm) between the implant coronal margin and the implant apex as assessed at the midportion of the implant; and

  • residual bone height at the mesial (MI) and distal (DI) aspects of the implant: distance (in mm) between the line linking the coronal implant margin, and the first contact of the crestal bone on both mesial and distal sides of the implant.

To account for radiographic distortion, radiographic measurements on each radiograph were adjusted for a coefficient derived from the ratio: true length of the implant/IL.

The radiographic marginal bone loss (MBL) was calculated by subtracting the marginal bone level at T0 from marginal bone level at T1.

All measurements were carried out by a single trained examiner (RG) who had previously undergone a calibration session for radiographic assessment on a sample of 5 patients treated with the same implant system and not included in the study.

Statistical analysis

Due to a lack of published data to estimate the variations in outcome measures at the respective test and control abutments, a sample size calculation was not feasible. Data were analyzed using SPSS software version 13.0 (Chicago, IL, USA).

Mean values and standard deviations (mean ± SD) were calculated for each considered clinical parameter. The normal distribution of error terms and the validity of the model’s assumptions were assessed using a Q–Q plot. One-sided P values were calculated and corrected according to Sidak’s method for multiple hypothesis testing. Data were analyzed by means of Mann–Whitney test and by repeated-measure analysis of variance (ANOVA). The Bonferroni test was applied for the pairwise comparison. A P value < 0.05 was considered statistically significant. Results of the linear mixed effects were used to calculate the estimates of the differences between groups and their 95% confidence intervals.

Clinical results

Table 1 reports the demographics and healing/prosthetic abutments data of the study population. The mPI for MS vs LMS at T0 and T1 were 0.7 ± 0.2 vs. 0.6 ± 0.3 and 0.4 ± 0.2 vs. 0.5 ± 0.1, respectively (Fig. 2). There was no significant difference between T0 and T1 in either group (P > 0.05). Similarly, minimal gingival inflammation was noted throughout the study in both groups. At T0 and T1, the mGI for MS was 0.5 ± 0.13 and 0.4 ± 0.21, respectively. At the same time points, the mGI for LM was 0.4 ± 0.14 and 0.5 ± 0.22, respectively. There was no significant difference between T0 and T1 in either group (P > 0.05) (Fig. 2). The BoP for LMS vs MS were 7.8 ± 0.2 and 8.9 ± 0.8, respectively at T0 and 8.2 ± 0.7 vs. 9.4 ± 0.4 respectively at T1 (Fig. 3). There was no significant difference between T0 and T1 in either group (P > 0.05), while differences between MS and LMS at each time point were statistically significant (P < 0.05). Between T0 and T1, a statistically significant increase pattern in the MS group was noted for PD (P < 0.05), while in the LMS group, PD showed no statistically significant increase (Fig. 3). In the LMS group, the mean PD at T0 and T1 were 0.9 ± 0.3 mm and 1.1 ± 0.2 mm, respectively. In MS, the mean PD at T0 and T1 were 1.8 ± 0.4 mm and 2.1 ± 0.1 mm, respectively. Difference in PD between the MS and LMS groups was statistically significant at each time point (P < 0.05).

Fig. 2
figure2

Mean mPI and mGI values recorded around LMS and MS abutments during the study period

Fig. 3
figure3

Mean BoP and PD values recorded around LMS and MS abutments during the study period

Biochemical results

PICF total volumes for MS vs LMS were 0.22 ± 1.5 μL vs. 0.20 ± 1.5 μL at BSL, 0.35 ± 0.16 μL vs. 0.26 ± 0.12 μL at T0, and 0.48 ± 0.12 μL vs. 0.24 ± 0.18 μL at T1 (Table 2, Fig. 4). Differences between T0 and T1 were statistically significant only for the MS group. Between-group comparisons revealed significant difference (P < 0.05) for the MS and LMS groups at each time point. The biomechanical results are reported in Tables 3, 4, 5 and 6 and shown in Figs. 5, 6, and 7. In the MS group, IL-1β and IL-6 showed a significant difference over time, while TNF-α showed no significant difference between T0 and T1. In the LMS group, IL-1β, IL-6, and TNF-α showed no significant difference between over time. At each time point, a significant difference between the MS and LMS groups was detected for IL-1β and IL-6.

Table 2 Comparison of the mean value of PICF (μl) detected in the LMS and MS groups
Fig 4
figure4

Mean values of PICF (μl) detected in the LMS and MS groups

Table 3 Comparison of the level of interleukin 1β (pg/mL) detected in the LMS and MS groups
Table 4 Comparison of the level of interleukin IL-6 (pg/mL) detected in the LMS and MS groups
Table 5 Comparison of the level of tumor necrosis factor (TNF)-α (pg/mL) detected in the LMS and MS groups
Table 6 Peri-implant radiographic bone levels (mm) detected in the LMS and MS groups
Fig. 5
figure5

Mean levels of interleukin 1β (pg/mL) detected in the LMS and MS groups

Fig. 6
figure6

Comparison of the level of interleukin IL-6 (pg/mL) detected in the LMS and MS groups

Fig. 7
figure7

Comparison of the level of tumor necrosis factor (TNF)-α (pg/mL) detected in LMS and MS

Radiographic results

Between T0 and T1, in the MS group the mean radiographic MBL was 0.36 ± 0.06 mm, while in the LMS group, it was 0.25 ± 0.17 mm. The difference between the MS and LMS groups was noted to be statistically significant (P < 0.05) (Table 6).

Discussion

Before final prosthesis fabrication, healing abutments must be disconnected and reconnected several times for impression making, metal framework try-in, and delivery of definitive abutments. It has been histologically documented that the dis/reconnected manipulation of healing abutment may mechanically injure the soft tissue barrier and disrupt the established mucosal seal, leading to an apical shift of the connective tissue attachment and remodelling of the underlying bone. Frequently, these histological changes clinically result in apical repositioning of the soft tissues [25, 32].

In the present study, the one-stage surgical protocol, with immediate placement of healing abutments, allowed optimal soft tissue access to evaluate both the healing period following implant placement (12/16 weeks) and both the restorative phases (3 weeks). It is known that the peri-implant soft tissue clinical maturity is established 4 weeks following implant placement by a one-stage surgical protocol [33]. Moreover, it has also been documented that the type of peri-implant tissue organization during soft tissue clinical maturity is influenced by transmucosal implant geometry and surface. While a smooth two-dimensional surface may lead to a flat arrangement of cell attachments and a consequent extensive spreading and de-differentiation [34, 35], a three-dimensional roughened or bio-activated surface, conversely, was demonstrated to induce cell differentiation, according to the so-called “contact guidance” concept [36]. During the soft tissue healing phase following implant placement, microgeometric or biofunctional surface modifications may induce fibroblast stabilization and differentiation, which promote connective tissue adaptation to the transmucosal part of the implant. In the present study, at the end of the healing period following implant placement, a significant statistical difference in PD and BoP was found between LMS vs MS. Therefore, it is possible to assume that during the observation periods, surfaces created with a laser on healing abutments may have influenced the soft tissue healing, improving soft tissue adhesion and creating a more robust perpendicular collagen fiber attachment [18,19,20,21].

Better results in PD and BoP around LMS vs. MS abutments were found also in a recent study by Schwarz et al. [37]. Authors evaluated clinically, biochemically, and microbiologically the response of the peri-implant soft tissue around LMS and MS abutments during a wound healing period following implant placement (12 weeks), a plaque exposure phase (21 days), and a resolution phase (16 weeks). At the end of the wound healing period, the 46.2% of the MS and merely 13.3% of the LMS abutments revealed a positive BoP. Moreover, the mean BoP tended to be higher at MS compared with LMS abutments, even if the difference did not reach statistical significance. As regards the PD, at the end of the wound healing period, MS and LMS abutments showed a similar mean PD value; at the end of the plaque exposure and resolution phases in the LMS group, the PD was reduced on average by 0.15 mm, while in the MS group, it increased on average by 0.8 mm.

Histological studies in animals and humans provided evidence of reattachment of the connective tissue when a laser-microgrooved healing abutment was replaced with another laser-microgrooved healing or definitive abutment [19, 21, 23]. In this context, in the MS group of the current study, PD showed a statistically significant increase during the restorative phase (between T0 and T1), while in the LMS group, it remained mostly constant. The time interval between T0 and T1 corresponds with prosthetic procedures (impression, proving of crown frame and proving of crown porcelain) during which replacement of the healing abutment was repeated at least three times. Therefore, it is possible to assume that the lower mean values of PD and BoP recorded in the current study at the end of the restorative phase (T1) in the LMS group may be connected to different response of peri-implant gingival tissues to repeated disconnection/reconnection of LMS and MS abutments. It must be emphasized that at each visit, a professionally administered plaque removal at the respective implants and remaining teeth was provided in each patient, who had previously been instructed about suitable oral hygiene and effective plaque control around the healing abutment. This may have undone the possible susceptibility of LMS surfaces to an undisturbed plaque formation, reported in the study by Schwarz et al. [37] as the cause of the higher incidence of diseased LMS vs. MS implants noted at the end of the plaque exposure phase (21 days). The observations of the present study basically corroborates the findings of previous clinical studies which pointed out that in patients enrolled in a professional, strict controlled oral hygiene regimen, LMS implants, compared with implants without LMS, are not more vulnerable to pathogenic microflora colonization [38, 39].

When further analyzing the present data, it was also noted that multiple abutment disconnections/reconnections could have a modest effect on marginal bone level changes regardless of the type of surface of the abutments. In this regard, LMS showed less vertical bone loss (0.11 mm), but the difference is of slight clinical significance. The reason for the slight difference may be that the hard tissue change around the implant is a very complex process which takes longer to manifest than those used in the current study, and that the abutment manipulation is not the only factor to affect the change.

Changes in PICF flow rate and IL-1, IL-1β, and TNF-α profiles evaluated during the current study allowed to get specific information on early metabolic and biomechanical responses around LMS and MS abutments [27, 31, 40]. The higher mean values of PICF flow rate and IL-6 and IL-1β levels recorded around MS abutments at all time points suggests a worsening in peri-implant soft tissue health, that coincides with the higher clinical inflammatory scores recorded around MS abutments compared with LMS. Moreover, in the MS group, PICF flow rate and IL-6 and IL-1β levels increased significantly during the restorative phase (between T0 and T1), while in the LMS group at the same time points, levels remained almost constant. It has been documented that the volumes of PICF increases as a function of greater vascular permeability and ulceration of the epithelium at inflamed sites and that it is directly related to the severity of the tissue inflammation. IL-6 and IL-1β are reliable markers of injury severity in the acute inflammatory response [41,42,43,44], and their principal role in gingival tissue is facilitating the healing process by protecting an open wound from bacterial infiltrate [45]. Accordingly, their prolonged production may reflect the extent of tissue trauma and delayed wound healing [46].

A limitation of the current study may be the short follow-up (4 weeks) which does not allow to compare the intensity of the cellular events in peri-implant tissues after implant loading.

Based on the clinical and biochemical results of the current study, it is possible to hypothesize that multiple abutment disconnections/reconnections lead to a different molecular response of peri-implant tissue around LMS and MS, probably connected to different aspects of peri-implant tissue anatomy and physiology (e.g., healing processes). However additional studies with histological analysis and longer follow-up are necessary to confirm these results.

Conclusion

Within the limits of the present study, it is possible to conclude that multiple disconnections/reconnections of LMS healing abutments resulted in less inflammation compared to conventional MS abutments. The advantage is substantial when repeated removal and replacement of abutments is necessary in the restorative phase.

Availability of data and materials

The datasets used and analyzed during the current study are available from the corresponding author on reasonable request.

Abbreviations

LMS:

Laser microgrooved surface

SM:

Machined surface

T0:

Time zero (definitive prosthetic abutment installation)

T1:

Time 1 (1 year after functional loading)

PICF:

Peri-implant crevicular fluid

IL-1β:

Interleukin-1beta

IL-6:

Interleukin-6

TNF-α:

Tumor necrosis factor alfa

ELISA:

Enzyme-linked immunosorbent assay

PD:

Probing depth

MBL:

Marginal bone loss

mPI:

Modified plaque index

mSBI:

Modified sulcular bleeding index

BoP:

Bleeding on probing

GCF:

Gingival crevicular fluid

CBCT:

Cone beam computed tomography

FMPS:

Full-mouth plaque score

FMBS:

Full-mouth bleeding score

RG:

Renzo Guarnieri

LT:

Luca Testarelli

Kw:

Kilowatt

mA:

Milliampere

IL:

Implant length

MI:

Mesial implant aspect

DI:

Distal implant aspect

References

  1. 1.

    Comut AA, Weber HP, Shortkroff S, Cui FZ, Spector M. Connective tissue orientation around dental implants in a canine model. Clin Oral Implants Res. 2001;12:433–40.

    Article  Google Scholar 

  2. 2.

    Abrahamsson I, Zitzmann NU, Berglundh T, Linder E, Wennerberg A, Lindhe J. The mucosal attachment to titanium implants with different surface characteristics: An experimental study in dogs. J Clin Periodontol. 2002;29(5):448–55.

    Article  Google Scholar 

  3. 3.

    Mustafa K, Odén A, Wennerberg A, Hultenby K, Arvidson K. The influence of surface topography of ceramic abutments on the attachment and proliferation of human oral fibroblasts. Biomat. 2005;26(4):373–81.

    Article  Google Scholar 

  4. 4.

    Schwarz F, Ferrari D, Herten M, Mihatovic I, Wieland M, Sager M, Becker J. Effects of surface hydrophilicity and microtopography on early stages of soft and hard tissue integration at non-submerged titanium implants: an immunohistochemical study in dogs. J Periodontol. 2007;78:2171–84.

    Article  Google Scholar 

  5. 5.

    Schwarz F, Herten M, Sager M, Wieland M, Dard M, Becker J. Histological and immunohistochemical analysis of initial and early osseous integration at chemically modified and conventional SLA titanium implants: preliminary results of a pilot study in dogs. Clin Oral Implants Res. 2007;18:481–8.

    Article  Google Scholar 

  6. 6.

    Schwarz F, Herten M, Sager M, Wieland M, Dard M, Becker J. Histological and immunohistochemical analysis of initial and early subepithelial connective tissue attachment at chemically modified and conventional SLA titanium implants. A pilot study in dogs. Clin Oral Investig. 2007;11:245–55.

    Article  Google Scholar 

  7. 7.

    Tete S, Mastrangelo F, Bianchi A, Zizzari V, Scarano A. Collagen fiber orientation around machined titanium and zirconia dental implant necks: an animal study. Int J Oral Maxillofacial Impl. 2009;24:52–8.

    Google Scholar 

  8. 8.

    Nevins M, Kim DM, Jun S-H, Guze K, Schupbach P, Nevins ML. Histologic evidence of a connective tissue attachment to laser microgrooved abutments: A canine study. Int J of Periodont Res Dent. 2010;30(3):245–55.

    Google Scholar 

  9. 9.

    Kloss FR, Steinmuller-Nethl D, Stigler RG, Ennemoser T, Rasse M, Hachl O. In vivo investigation on connective tissue healing to polished surfaces with different surface wettability. Clin Oral Implants Res. 2011;22:699–705.

    Article  Google Scholar 

  10. 10.

    Chien H-H, Schroering RL, Prasad HS, Tatakis DN. Effects of a new implant abutment design on peri-implant soft tissues. J Oral Implantol. 2014;40(5):581–8.

    Article  Google Scholar 

  11. 11.

    Lee J-H, Kim Y-H, Choi E-H, Kim K-M, Kim K-N. (2015). Air atmospheric-pressure plasma-jet treatment enhances the attachment of human gingival fibroblasts for early peri-implant soft tissue seals on titanium dental implant abutments. Acta Odontol Scand. 2015;73(1):67–75.

    Article  Google Scholar 

  12. 12.

    Kim Y-S, Shin S-Y, Moon S-K, Yang S-M. Surface properties correlated with the human gingival fibroblasts attachment on various materials for implant abutments: A multiple regression analysis. Acta Odontol Scand. 2015;73(1):38–47.

    Article  Google Scholar 

  13. 13.

    Nothdurft FP, Fontana D, Ruppenthal S, May A, Aktas C, Mehraein Y, Kaestner L. Differential behavior of fibroblasts and epithelial cells on structured implant abutment materials: A comparison of materials and surface topographies. Clin Impl Dent Rel Res. 2015;17(6):1237–49.

    Article  Google Scholar 

  14. 14.

    Ricci J, Charvet J, Frenkel S, et al. Bone response to laser microtextured surfaces. In: Davies JE, editor. Bone Engineering. Toronto: Em2; 2000. p. 282–94.

    Google Scholar 

  15. 15.

    Ricci JL, Grew JC, Alexander H. Connective-tissue responses to defined biomaterial surfaces. I. Growth of rat fibroblast and bone marrow cell colonies on microgrooved substrates. J Biom Mat Res A. 2008;85:313–25.

    Article  Google Scholar 

  16. 16.

    Grew JC, Ricci JL, Alexander H. Connective-tissue responses to defined biomaterial surfaces. II. Behavior of rat and mouse fibroblasts cultured on microgrooved substrates. J Biom Mat Res A. 2008;85:326–35.

    Article  Google Scholar 

  17. 17.

    Heinrich A, Dengler K, Koerner T, Haczek C, Deppe H, Stritzker B. Laser-modified titanium implants for improved cell adhesion. Lasers Med Sci. 2008;23:55–8.

    Article  Google Scholar 

  18. 18.

    Nevins M, Nevins ML, Camelo M, Boyesen JL, Kim DM. Human histologic evidence of a connective tissue attachment to a dental implant. Int J Period Rest Dent. 2008;28:111–21.

    Google Scholar 

  19. 19.

    Nevins M, Camelo M, Nevins ML, Schupbach P, Kim DM. Connective tissue attachment to laser-microgrooved abutments: A human histologic case report. Int J Period Rest Dent. 2012;32:385–92.

    Google Scholar 

  20. 20.

    Geurs NC, Vassilopoulos PJ, Reddy MS. Histologic evidence of connective tissue integration on laser microgrooved abutments in humans. Clin Adv Periodont. 2011;1:29–33.

    Article  Google Scholar 

  21. 21.

    Iglhaut G, Becker K, Golubovic V, Schliephake H, Mihatovic I. The impact of dis-/reconnection of laser microgrooved and machined implant abutments on soft- and hard-tissue healing. Clin Oral Implants Res. 2013;24:391–7.

    Article  Google Scholar 

  22. 22.

    Neiva R, Tovar N, Jimbo R, Gil L, Goldberg P, Barbosa J, Coelho P. Guidelines for clinical management of laser-etched (Laser-Lok) abutments in two different clinical scenarios: A preclinical laboratory soft tissue assessment study. Int J Periodont Rest Dent. 2016;36(3):339–45.

    Google Scholar 

  23. 23.

    Blázquez-Hinarejos M, Ayuso-Montero R, Álvarez-López JM, Manzanares-Céspedes MC, López-López J. Histological differences in the adherence of connective tissue to laser-treated abutments and standard abutments for dental implants. An experimental pilot study in humans. Med Oral Patol Oral Cir Bucal. 2017;22(6):e774–9.

    PubMed  PubMed Central  Google Scholar 

  24. 24.

    Kuppusamy M, Watanabe H, Kasugai S, Kuroda S. Effects of abutment removal and reconnection on inflammatory cytokine production around dental implants. Impl Dent. 2015;24(6):730–4.

    Google Scholar 

  25. 25.

    Abrahamsson I, Berglundh T, Lindhe J. The mucosal barrier following abutment dis/ reconnection. An experimental study in dogs. J Clin Periodontol. 1997;24:568–72.

    Article  Google Scholar 

  26. 26.

    Barros SP, Williams R, Offenbacher S, Morelli T. Gingival crevicular fluid as a source of biomarkers for periodontitis. Periodontol. 2016;70(1):53–64.

    Article  Google Scholar 

  27. 27.

    Tözüm TF, Akman AC, Yamalik N, et al. Analysis of the inflammatory process around endosseous dental implants and natural teeth: myeloperoxidase level and nitric oxide metabolism. Int J Oral Maxillofac Implants. 2007;22(6):969–79.

    PubMed  Google Scholar 

  28. 28.

    Sakallıoğlu U, Lütfioğlu M, Sakallıoğlu EE, Sert S, Ceylan G. Osmotic pressure of periimplant sulcular and gingival crevicular fluids: a splitmouth, randomized study of its measurement and clinical significance. Clin Oral Implants Res. 2011;22(7):706–10.

    Article  Google Scholar 

  29. 29.

    Panagakos FS, Aboyoussef H, Dondero R, Jandinski JJ. Detection and measurement of inflammatory cytokines in implant crevicular fluid: a pilot study. Int J Oral Maxillofac Implants. 1996;11(6):794–9.

    PubMed  Google Scholar 

  30. 30.

    Javed F, Al-Hezaimi K, Salameh Z, Almas K, Romanos GE. Proinflammatory cytokines in the crevicular fluid of patients with peri-implantitis. Cytok. 2011;53(1):8–12.

    Article  Google Scholar 

  31. 31.

    Dursun E, Tözüm TF. Peri-Implant Crevicular Fluid Analysis, Enzymes and Biomarkers: a Systemetic Review. J Oral Maxillofac Res. 2016;7(3):e9.

    Article  Google Scholar 

  32. 32.

    Rompen E. The impact of the type and configuration of abutments and their (repeated) removal on the attachment level and marginal bone. Eur J Oral Implantol. 2012;5(Suppl):S83–90 Erratum in: Eur J Oral Implantol. 2013 Winter;5(4):379. PMID: 22834397.

    PubMed  Google Scholar 

  33. 33.

    DeAngelo SJ, Kumar PS, Beck FM, Tatakis DN, Leblebicioglu B. Early soft tissue healing around one-stage dental implants: clinical and microbiologic parameters. J Periodontol. 2007;78(10):1878–86. https://doi.org/10.1902/jop.2007.070122 PMID: 18062110.

    Article  PubMed  Google Scholar 

  34. 34.

    Ghibaudo M, Trichet L, Le Digabel J, Richert A, Hersen P, Ladoux B. Substrate topography induces a crossover from 2D to 3D behavior in fibroblast migration. Biophys J. 2009;97(1):357–68. https://doi.org/10.1016/j.bpj.2009.04.024 PMID: 19580774; PMCID: PMC2711370.

    Article  PubMed  PubMed Central  Google Scholar 

  35. 35.

    Weiss P, Garber B. Shape and Movement of Mesenchyme Cells as Functions of the Physical Structure of the Medium: Contributions to a Quantitative Morphology. Proc Natl Acad Sci U S A. 1952;38(3):264–80. https://doi.org/10.1073/pnas.38.3.264 PMID: 16589090.

    Article  PubMed  PubMed Central  Google Scholar 

  36. 36.

    Kunzler TP, Drobek T, Schuler M, Spencer ND. Systematic study of osteoblast and fibroblast response to roughness by means of surface-morphology gradients. Biomaterials. 2007;28(13):2175–82. https://doi.org/10.1016/j.biomaterials.2007.01.019 Epub 2007 Jan 14. PMID: 17275082.

    Article  PubMed  Google Scholar 

  37. 37.

    Schwarz F, Becker J, Civale S, Hazar D, Iglhaut T, Iglhaut G. Onset, progression and resolution of experimental peri-implant mucositis at different abutment surfaces: A randomized controlled two-centre study. J Clin Periodontol. 2018;45(4):471–83. https://doi.org/10.1111/jcpe.12868 Epub 2018 Feb 7. PMID.

    Article  PubMed  Google Scholar 

  38. 38.

    Guarnieri R, Rappelli G, Piemontese M, Procaccini M, Quaranta A. A Double-Blind Randomized Trial Comparing Implants with Laser-Microtextured and Machined Collar Surfaces: Microbiologic and Clinical Results. Int J Oral Maxillofac Implants. 2016;31(5):1117–25. https://doi.org/10.11607/jomi.4563 PMID: 27632268.

    Article  PubMed  Google Scholar 

  39. 39.

    Guarnieri R, Grande M, Zuffetti F, Testori T. Incidence of Peri-implant Diseases on Implants With and Without Laser-Microgrooved Collar: A 5-Year Retrospective Study Carried Out in Private Practice Patients. Int J Oral Maxillofac Implants. 2018;33(2):457–65. https://doi.org/10.11607/jomi.6178 PMID: 29534135.

    Article  PubMed  Google Scholar 

  40. 40.

    Bhardwaj S, Prabhuji ML. Comparative volumetric and clinical evaluation of peri-implant sulcular fluid and gingival crevicular fluid. J Periodont Impl Sci. 2013;43(5):233–42.

    Article  Google Scholar 

  41. 41.

    Jawa RS, Anillo S, Huntoon K, Baumann H, Kulaylat M. Analytic review: interleukin-6 in surgery, trauma, and critical care: part I: basic science. J Intensive Care Med. 2011;26(1):3–12.

    Article  Google Scholar 

  42. 42.

    Jawa RS, Anillo S, Huntoon K, Baumann H, Kulaylat M. Interleukin-6 in surgery, trauma, and critical care part II: clinical implications. J Intensive Care Med. 2011;26(2):73–87.

    Article  Google Scholar 

  43. 43.

    Bartold PM, Haynes DR. Interleukin-6 production by human gingival fibroblasts. J Periodontal Res. 1991;26(4):339–45.

    Article  Google Scholar 

  44. 44.

    Bielemann AM, Marcello-Machado RM, Leite FRM, Martinho FC, Chagas-Júnior OL, Antoninha Del Bel Cury A, Faot F. Comparison between inflammation related markers in periimplant crevicular fluid and clinical parameters during osseointegration in edentulous jaws. Clin Oral Investig. 22(1):531–43.

  45. 45.

    Graves DT, Nooh N, Gillen T, Davey M, Patel S, Cottrell D, Amar S. IL-1 plays a critical role in oral, but not dermal, wound healing. J Immunol. 2001;167(9):5316–20.

    Article  Google Scholar 

  46. 46.

    Ghassib I, Chen Z, Zhu J, Wang HL. Use of IL-1 β, IL-6, TNF-α, and MMP-8 biomarkers to distinguish peri-implant diseases: A systematic review and meta-analysis. Clin Impl Dent Rel Res. 2019;21(1):190–207.

    Article  Google Scholar 

Download references

Acknowledgements

Not applicable

Funding

The study was supported by La Sapienza University of Rome, Department of Oral and Maxillo-Facial Sciences, Italy.

Author information

Affiliations

Authors

Contributions

Renzo Guarnieri and Luca Testarelli: substantial contributions to research design and drafting of the paper. Gabriele Miccoli, Rodolfo Reda, Alessandro Mazzoni, and Dario Di Nardo: data acquisition and analysis. All authors: data interpretation, revising the paper critically, agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any parts of the work are appropriately investigated and resolved, and approval of the submitted and final version

Corresponding author

Correspondence to Renzo Guarnieri.

Ethics declarations

Ethics approval and consent to participate

Each patient was informed about the evidence-based positive outcome of implant treatment and signed a free informed consent form after he/she has received detailed information about the study. Treatments were performed according to the principles outlined in the Declaration of Helsinki on experimentation involving human subjects. The study was approved by the Research Ethics Committee of the La Sapienza University of Rome (#4597). Trial registration: ClinicalTrials.gov NCT04415801, registered 03/06/2020, https://register.clinicaltrials.gov/prs/app/action/SelectProtocol?sid=S0009V52&selectaction=Edit&uid=U0003LQX&ts=24&cx=-mviyyi.

Consent for publication

Not applicable

Competing interests

Renzo Guarnieri, Gabriele Miccoli, Rodolfo Reda, Alessandro Mazzoni, Dario Di Nardo, and Luca Testarelli state that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Guarnieri, R., Miccoli, G., Reda, R. et al. Laser microgrooved vs. machined healing abutment disconnection/reconnection: a comparative clinical, radiographical and biochemical study with split-mouth design. Int J Implant Dent 7, 19 (2021). https://doi.org/10.1186/s40729-021-00301-6

Download citation

Keywords

  • Peri-implant crevicular fluid
  • Inflammation
  • Abutments
  • Cytokines
\